Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Add Lloyds Banking Group (LLOY) by John Choong in The Motley Fool
- Buy Barclays (BARC) by John Choong in The Motley Fool
- Buy Tharisa (DI) (THS) by Hot Stock Rockets in ShareProphets
- Long Term Buy Glencore (GLEN) by Alan Oscroft in The Motley Fool
- Buy British American Tobacco (BATS) by Christopher Ruane in The Motley Fool
- Sell Strix Group (KETL) by Steve Moore in ShareProphets
- Hold Lloyds Banking Group (LLOY) by Charlie Carman in The Motley Fool
- Buy M&G (MNG) by Christopher Ruane in The Motley Fool
- Buy JD Sports Fashion (JD.) by Christopher Ruane in The Motley Fool
- Buy Mondi (MNDI) by Christopher Ruane in The Motley Fool
- Avoid Loopup Group (LOOP) by Steve Moore in ShareProphets
- Buy Next (NXT) by Chris Bailey in ShareProphets
- Buy Next (NXT) by Bank of America
- Buy BAE Systems (BA.) by Bank of America
- Sell Versarien (VRS) by Tom Winnifrith in ShareProphets
- Risky Buy Ashtead Group (AHT) by Edward Sheldon in The Motley Fool
- Long Term Buy The Renewables Infrastructure Group Limited (TRIG) by Edward Sheldon in The Motley Fool
- Long Term Buy Cerillion (CER) by Edward Sheldon in The Motley Fool
- Buy easyJet (EZJ) by John Choong in The Motley Fool
- Watch Aston Martin Lagonda Global Holdings (AML) by John Fieldsend in The Motley Fool
Hikma Pharmaceuticals (HIK)
Health Care Sector
Members only
To view this content and much more please Sign Up
NOTE: This is based on 316 open tips for this company
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jefferies | – | 2023-03-13 04:26:00 13/03/2023 | – |
| – | JP Morgan | – | 2023-03-09 04:37:00 09/03/2023 | – |
| – | Goldman Sachs | – | 2023-03-06 06:03:00 06/03/2023 | – |
| – | RBC Capital | – | 2023-03-01 05:58:00 01/03/2023 | – |
| – | Berenberg | – | 2023-02-27 05:39:00 27/02/2023 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jefferies | – | 2023-03-13 04:26:00 13/03/2023 | – |
| – | JP Morgan | – | 2023-03-09 04:37:00 09/03/2023 | – |
| – | Goldman Sachs | – | 2023-03-06 06:03:00 06/03/2023 | – |
| – | RBC Capital | – | 2023-03-01 05:58:00 01/03/2023 | – |
| – | Berenberg | – | 2023-02-27 05:39:00 27/02/2023 | – |